Activity of clinafloxacin against multidrug-resistant Enterococcus faecium.
Enterococci resistant to ampicillin, vancomycin, and/or aminoglycosides are a growing clinical problem. We studied the in vitro activity of the new fluoroquinolone clinafloxacin (PD 127,391) against 15 clinical isolates of multidrug-resistant Enterococcus faecium. In kill-kinetic studies, clinafloxa...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1994
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284614/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7979306/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.7.1668 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
